He developed this medical Technology and received FDA 510k Clearance, August 1993.
Available in Europe, Canada and the U.S.A. Currently Medical Offices in 58 Countries Provide Neurocare.
FDA Registered Uses:
Please See FDA Letter Below:
NEUROCARE™ Model: NC1000/4P
“THE THERAPEUTIC ELECTRICAL STIMULATOR”
Medical Conditions which have been treated with the Neurocare 1000™ since its release from the F.D. A. in 1993.
These conditions have been successfully treated by physicians(office/clinic application)and their patients(home application) using the Neurocare Treatment Program©.
1. Diabetic neuropathy 250.6x insulin dependent or not
2. Diabetic neuropathy of the feet 355.8
3. Peroneal palsey “drop foot” 736.79
4. Bells Palsey of the face 351.0
5. Trigeminal neuralgia 350.1
6. Sciatica –see condition 355.0
7. AIDS neuropathy 355.5
8. Tarsal tunnel syndrome 355.5
9. Alcoholic polyneuropathy 357.5
10. Hereditary progressive muscle 356.2
11. Hereditary progressive muscle dystrophy 356.1
12. Parasthesia feet NOS 782.0
13. Parasthesia hands NOS 782.0
14. Ulnar nerve lesion 354.2
15. Foot neuroma metatarsals 355.6
16. Chemotherapy induced neuropathy 357.6
17. Neuropathy of pernicious anemia 281.0
CHRONIC PAIN SYNDROMES
18. Low back pain 724.2
19. Upper back pain due to fibromyalgia 729.1
20. Chronic tendonitis 726.90
21. Shoulders 719.41 22. Neck 723.1
23. Decubitus ulcers 250.8x - 707.0 (verify area)
24. Toes 250.8x – 707.15
25. Heel 250.8x – 707.14
26. Calf 250.8x – 707.12
27. Tibial surface 250.8x – 707.10
28. Plantar surface 250.8x -- 707.15
29. Stasis ulcers 454.0
PRESSURE ULCERS IN IMMOBILE PATIENTS
30. Heel 707.0
31. Greater trochanter 707.0
32. Sacrum 707.0
33. Ischial tuberosity BONE FRACTURES (accelerates healing)
34. “Marching/diabetic fracture” of metatarsals 825.25
35. Avulsion fracture distal fibula 824.8
36. Femur mid shaft fracture 821.00
37. Femur impacted head fracture 820.09
38. Radial head fracture 813.07
39. Humeral head fracture 812.09
40. Humeral mid shaft fracture 812.21
41. Navicular fracture in wrist 814.01
42. Fracture of radius & ulna 813
43. Fracture of tibia & fibula 823
44. Traumatic compression fracture in lumbar spine 805.xx
45. Traumatic compression fracture in thoracic spine 805.xx
ISCHEMIC REST PAIN (ARTERIAL INSUFFICIENCY
46. Feet 443.9
47. Calf 443.9
48. Thigh 443.9
OSTEOPOROSIS/OSTEOARTHRITIS/DEGENERATIVE JOINT DISEASE
49. Spontaneous compression fracture in lumbar spine 733.13
50. Spontaneous compression fracture in thoracic spine 733.13
51. Chronic hip pain from osteoporosis 719.45/733.00
52. Degenerative arthritis knee 715.16
53. Degenerative arthritis hip 715.15
54. Degenerative arthritis ankles 715.17
55. Osteoarthritis hand 715.14
56. Osteomyelitis of bone ( used w/systemic antibiotics) 730.x
57. Generalized bone healing (not a diagnosis) DISUSE ATROPHY
58. Bedfast conditions – lower and upper extremity wasting 728.2
59. Muscle wasting conditions such as multiple sclerosis 340
60. Muscle atrophy 728.2
61. Parkinson’s disease 332.0
PARAPLEGIA AND QUADRIPLEGIA 344.1 & 344.0
62. Ischial tuberosity decubitus 707.09
63. Carpal tunnel syndrome 354.0
64. Lateral epicondylitis (Tennis elbow) 726.32
65. Medial epicondylitis (Golfer’s elbow) 726.31
66. Plantar fascitis 728.71
67. Costochondritis 733.6
PERIPHERAL NERVE INJURIES
68. Hand 755.7
69. Forearm 755.7
70. Upper arm 755.7
71. Lower legs 756.5
SPORTS INJURIES & ACUTE SPRAIN/STRAIN
72. Ankle lateral sprain first or second degree 845.00
73. Knee strain medial or lateral 844.1 collateral ligament 717.81
74. Wrist 842.00
75. Shoulder strain 840.9
76. Elbow 841.00
77. Neck acute cervical strain 847.0
78. Pulled Hamstring 843.9
79. Muscle Spasm in Back 724.8
80. Muscle spasm 728.85
81. Incontinence 788.3x
82. Frostbite 991-991.9 (verify location)
83. Localized second and third degree burns 949
84. Post radiation burns ulcerated or poorly healing
85. Post polio syndrome (symptoms of) 138
86. Lymphedema 757.0
87. Raynaud’s Disease 443.0
88. Buerger’s disease 443.1
89. Infantile Cerebral palsy 343.
90. Muscular wasting & disuse 728.2
91. Muscle weakness 728.87
92. Post-surgical rehabilitation (overcoming disuse atrophy, muscle wasting, swelling/edema, increase range of motion) Use the code for the surgery or one of these listed here.
"I wonder if Neurocare can help with this . . .condition?"
A better question to ask when determining if the Neurocare treatment program may be effective with a specific diagnosis:
“Does the problem or the symptom have anything to due with a muscular or nerve impairment or a restriction of circulation?”
My wife and I are Independent Representatives of Neurocare USA, Inc.
"It is our goal to proclaim the benefits of this 'tried and true' technology to everyone who is seeking relief from the conditions mentioned above."
If we can be of assistance - please call or email us via our Contact Us tab above.
Thank You and May The Lord Bless You!
John & Marlene Clayton
Clinic where 100's of patients have been treated with Neurocare-Oklahoma City, OK
A story of Neurocare, the technology, programs, and company, which have evolved over the years. Founders Tom & Debbie Oliver presented Neurocare to the FDA in early 1993 and it was accepted as a Class 2 Medical Device in August of 1993.
Through the years, Mr. & Mrs. Oliver have overseen studies from major universities like Creighton University in Omaha; Mexico City, Mexico and more recently in the United Kingdom. Neurocare technology was designed as a neuromuscular electronic stimulator out of a need for Tom’s recovery from an automobile accident that “should” have left him paralyzed from the neck down. By the grace of God, Tom was spared from a diagnosis of being a quadriplegic. Through the years that followed Tom learned how to reverse many of the “paralyzing” symptoms that may have “doomed” others.
If you are hearing this and know of someone who is paralyzed, I encourage you to have them call 1-877-571-3599 and talk with one of the clinicians for more information.
What I’d like to explain to you next is how God gave Neurocare technology to Mr. Oliver. After Mr. Oliver’s injury he was placed on high doses of pain medications, which did nothing but make him lethargic, unable to function, and cause an increase in disuse atrophy and inflammation. Tom consulted with medical providers for assistance to find something more effective. They suggested surgery which would have placed rods in his spine! Are you surprised he refused? He began researching non-invasive technologies. He came across the EMS units available at the time (1970-80); however found these only provided a small degree of relief, nothing long-lasting. He wondered why something more effective was not available?
After studying and evaluating the electrotherapy technologies being used, he discovered all of the modalities were only designed for DC output. Because of his training in school and later in the Navy he deduced that for more successful results he needed a current that could overcome the resistance of his injury and the distance within his body that needed to be treated. This all led him to develop the AC output technology that makes Neurocare today so effective.
The Oliver’s remain an active part of the company. They have become advisors, authors, trainers and participant in our Clinical Department. HOPE REVEALED!!!
Neurocare and Tom & Debbie Oliver